1. Home
  2. ZEPP vs DXR Comparison

ZEPP vs DXR Comparison

Compare ZEPP & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZEPP
  • DXR
  • Stock Information
  • Founded
  • ZEPP 2013
  • DXR 1970
  • Country
  • ZEPP Netherlands
  • DXR United States
  • Employees
  • ZEPP N/A
  • DXR N/A
  • Industry
  • ZEPP Computer Manufacturing
  • DXR Medical/Dental Instruments
  • Sector
  • ZEPP Technology
  • DXR Health Care
  • Exchange
  • ZEPP Nasdaq
  • DXR Nasdaq
  • Market Cap
  • ZEPP 35.1M
  • DXR 36.4M
  • IPO Year
  • ZEPP N/A
  • DXR N/A
  • Fundamental
  • Price
  • ZEPP $2.90
  • DXR $9.65
  • Analyst Decision
  • ZEPP
  • DXR Strong Buy
  • Analyst Count
  • ZEPP 0
  • DXR 1
  • Target Price
  • ZEPP N/A
  • DXR $25.00
  • AVG Volume (30 Days)
  • ZEPP 19.6K
  • DXR 6.0K
  • Earning Date
  • ZEPP 08-20-2025
  • DXR 01-01-0001
  • Dividend Yield
  • ZEPP N/A
  • DXR N/A
  • EPS Growth
  • ZEPP N/A
  • DXR 86.16
  • EPS
  • ZEPP N/A
  • DXR 0.11
  • Revenue
  • ZEPP $181,183,000.00
  • DXR $119,714.00
  • Revenue This Year
  • ZEPP $758.69
  • DXR N/A
  • Revenue Next Year
  • ZEPP N/A
  • DXR N/A
  • P/E Ratio
  • ZEPP N/A
  • DXR $90.07
  • Revenue Growth
  • ZEPP N/A
  • DXR N/A
  • 52 Week Low
  • ZEPP $2.06
  • DXR $6.55
  • 52 Week High
  • ZEPP $4.38
  • DXR $10.00
  • Technical
  • Relative Strength Index (RSI)
  • ZEPP 58.03
  • DXR 63.02
  • Support Level
  • ZEPP $2.50
  • DXR $8.68
  • Resistance Level
  • ZEPP $2.80
  • DXR $9.79
  • Average True Range (ATR)
  • ZEPP 0.16
  • DXR 0.46
  • MACD
  • ZEPP 0.04
  • DXR 0.02
  • Stochastic Oscillator
  • ZEPP 75.45
  • DXR 89.55

About ZEPP Zepp Health Corporation

Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands.

About DXR Daxor Corporation

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

Share on Social Networks: